$NVTA (-10.1% pre) Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow and Realize Full Potential of Industry-Leading Genetics Testing Platform - PRN   https://t.co/dGdEMtXZQv